> It means pharmacists will no longer be able to offer a range of brands for generic drugs and instead will be supplied by the generic drug maker chosen by the province.

Aren't we talking about "generic" drugs that are supposed to be copies of brand-name drugs that have gone off-patent? I fail to see how the pharmacist no longer being able to pick-and-choose between three versions of a "generic" drug is much of a hardship. 

Maybe it has something to do with the rebates the manufacturers offer to the pharmacists?